Search Results - "Volkov, Nikita P"
-
1
Efficacy and safety of nivolumab combined with brentuximab vedotin after nivolumab monotherapy failure in patients with relapsed and refractory classic Hodgkin lymphoma
Published in International journal of clinical oncology (01-03-2022)“…Objectives Therapy of patients with relapsed and refractory classic Hodgkin lymphoma (r/r cHL) after PD-1 inhibitors failure remains an unresolved issue. The…”
Get full text
Journal Article -
2
Time-Dependent Shifts in Intestinal Bacteriome, Klebsiella Colonization and Incidence of Antibiotic-Resistance Genes after Allogeneic Hematopoietic Stem Cell Transplantation
Published in Biomedicines (15-07-2024)“…Dose-intensive cytostatic therapy and antibiotic treatment in allogeneic hematopoietic stem cell transplantation (allo-HSCT) cause severe abnormalities in a…”
Get full text
Journal Article -
3
A Phase 2 Study of Nivolumab Using a Fixed Dose of 40 mg (Nivo40) in Patients With Relapsed/Refractory Hodgkin Lymphoma
Published in HemaSphere (01-10-2020)“…Supplemental Digital Content is available in the text The introduction of nivolumab has changed the landscape of relapsed/refractory classical Hodgkin lymphoma…”
Get full text
Journal Article -
4
Safety of Allogeneic Stem Cell Transplantation after PD-1 Blockade for Patients with Relapsed/Refractory Classical Hodgkin Lymphoma: Focus on Immune-Related Adverse Events
Published in Blood (05-11-2020)“…▪ Introduction: Allogeneic hematopoietic stem cells transplantation (allo-HSCT) is a potentially curative option for patients with relapsed and refractory…”
Get full text
Journal Article -
5
Nivolumab in Primary CNS Lymphoma and Primary Testicular Lymphoma with CNS Involvement: Single Center Experience
Published in Blood (05-11-2020)“…Background.Most patients with primary CNS lymphoma (PCNSL), an aggressive extranodal lymphoma confined to the CNS, have a poor prognosis in spite of…”
Get full text
Journal Article